Skip to content
Compare prices

Independent UK medicine guidance

Mounjaro injection site reactions: redness and itching

Injection site reactions are a common Mounjaro side effect. They can include itching, redness, mild swelling or irritation around the place where the medicine was injected. This guide explains what a typical reaction looks like, how to reduce irritation, and when a reaction needs checking.

Written by: Nick Johnson, Independent Prescription Pricing Analyst, Medstack Ltd  |  Checked: 9 September 2026  |  Next scheduled review: 9 December 2026

Call 999Swelling of the lips, mouth, tongue or throat, breathing difficulty or collapse. That is not a routine injection site reaction.
Get it checkedA reaction that is spreading, hot, very painful, discharging pus or accompanied by a fever.

How common are they?

8%of participants taking tirzepatide reported injection site reactions in pooled weight-management studies
1.8%reported them while taking a placebo in the same studies
91% mildacross the phase 3 programme, with 9% moderate and none classed as serious

Where to inject

Mounjaro can be injected under the skin of the abdomen, thigh or back of the upper arm. Another person should administer injections into the back of your upper arm. The pink areas below show the recommended sites.

Recommended injection areas shown in pink: the stomach area (at least 5cm from the belly button), the front of the thighs, and the back or side of the upper arms. Open the interactive symptom map
Rotate every week. Choose a different point within the permitted area each time, at least one finger width from the last injection. If injecting into the abdomen, stay at least 5cm away from the navel. If you also use insulin, use a separate injection site for it.

What does a typical reaction look like?

A straightforward local reaction generally:

  • Appears close to the injection point
  • Causes mild redness, itching or tenderness
  • Does not continue rapidly spreading
  • Improves rather than worsening
  • Does not affect breathing or cause facial swelling

Redness can be more difficult to see on brown or black skin. Warmth, swelling, itching and tenderness may be easier signs to recognise.

Image placeholder 1
Mild local reactionSmall area of redness or itching close to the injection point, settling on its own.
Image placeholder 2
On brown or black skinRedness may be far less visible, so look for warmth, swelling, tenderness and texture change instead.
Image placeholder 3
Needs checkingSpreading, hot, very painful or discharging areas should be assessed rather than watched.

Image placeholders: replace with licensed or original photography before publication. Do not use patient images without documented consent.

How can you reduce irritation?

  • Avoid injecting into skin that is bruised, sore, hard, scarred or already inflamed
  • Use a new compatible pen needle for every injection and follow the instructions supplied with the KwikPen
  • Do not scratch the area
  • A wrapped cool compress may help with mild irritation. Avoid placing ice directly on the skin

Injection site reaction or allergy?

A small localised patch of itching or redness where the needle entered is usually an injection site reaction. It should remain limited to that area and generally settle. An allergic reaction may affect areas away from the injection site and can cause widespread hives, facial swelling or breathing difficulties.

Call 999 for swelling of the lips, mouth, tongue or throat, breathing difficulty, collapse or other signs of anaphylaxis. Anaphylaxis can progress quickly and should never be watched at home to see whether it gets worse.

Read the full guide to severe allergic reactions

When should it be checked?

Ask your pharmacist, prescriber or GP for advice if the reaction:

  • Becomes increasingly painful, hot or swollen
  • Continues to spread
  • Produces pus or discharge
  • Is accompanied by a fever
  • Fails to improve
  • Happens severely after every dose
Evidence update, September 2026: SURPASS-CVOT injection site figure in the revised SmPC

On 8 September 2026 the electronic medicines compendium (eMC) published a revised Mounjaro Summary of Product Characteristics with a text revision date of 29 August 2026. It adds safety results from SURPASS-CVOT, a large trial that compared tirzepatide with dulaglutide, another injectable diabetes medicine, in adults with type 2 diabetes and established cardiovascular disease. The study-specific figures relevant to this page are:

  • Injection site reactions: 1.5% of participants taking tirzepatide
  • Hypersensitivity reactions of any kind, including rash, itching and hives away from the injection site: 5.7%
Read before quoting these numbers. These results came from adults with type 2 diabetes and established cardiovascular disease in an active-comparator study. They should not be presented as expected rates for people taking Mounjaro solely for weight management.

The figure substantiates the frequency category recorded for that study population in the UK patient leaflet revised in August 2026. It does not add a new side effect and it does not change the advice above on telling a local reaction from an allergy.

Source: Mounjaro Summary of Product Characteristics (eMC), text revised 29 August 2026, section 4.8

Common questions

How common are Mounjaro injection site reactions?

In pooled tirzepatide weight-management studies, injection site reactions were reported by 8% of participants taking tirzepatide and 1.8% taking placebo. Across the phase 3 programme, 91% were mild and 9% were moderate; none was classed as serious.

Where can Mounjaro be injected?

Mounjaro can be injected under the skin of the abdomen, thigh or back of the upper arm. Another person should administer injections into the back of your upper arm. Choose a different point within the permitted area each week.

How do I tell an injection site reaction from an allergic reaction?

A small localised patch of itching or redness where the needle entered is usually an injection site reaction, and it should stay limited to that area. An allergic reaction may affect areas away from the injection site and can cause widespread hives, facial swelling or breathing difficulties, which needs emergency help.

Related guides

Skin & reactions
Using the pen
Wider side effects

Sources: Mounjaro Patient Information Leaflet (eMC) • Mounjaro Summary of Product Characteristics (eMC)

Explore other side effects

Tap a point on the body to jump to that symptom, or choose from the full list below. The pink marker shows where you are now.

Front Back Mounjaro Dizziness and Low Blood Pressure Does Mounjaro Cause Hair Loss? UK Evidence Explained Mounjaro Allergic Reaction: When to Call 999 Can Mounjaro Cause Low Blood Sugar? Mounjaro Nausea and Vomiting: What Helps? Mounjaro and Gallstones: Symptoms and Warning Signs Mounjaro Diarrhoea: Causes, Treatment and Warnings Injection sites: rear upper arm, stomach and thigh Rear upper arm Stomach Thigh Stomach Thigh Rear upper arm
Nausea & vomitingDiarrhoeaConstipationBurps, bloating & refluxGallstonesPancreatitisAllergic reactionsInjection siteSkin painHair lossFatigueFeeling coldDizzinessLow blood sugarKidneysHydrationMuscle & proteinSickness bug?Sick-day rulesSurgeryContraceptionHow long they last

Open the full interactive symptom map

About this guide

Written by: Nick Johnson, Independent Prescription Pricing Analyst, Medstack Ltd (Company No. 16439872). Sources for clinical statements are listed on this page and come from the electronic medicines compendium, the NHS, the MHRA and UK professional bodies.

Our role: Monj compares UK weight-loss medicine providers. This guide is editorial health information and does not replace advice from your prescriber, pharmacist or NHS services. Monj does not sell, prescribe or dispense medicines, and commercial arrangements do not change clinical content or safety routing. Mounjaro is the brand name; tirzepatide is the active ingredient. Spotted an error? Use our contact page to flag it.

© 2026 Medstack Ltd. Written and published by Monj (monj.co.uk). You are welcome to link to this page or quote a short extract with a credit and a link. Republishing the text, page structure, safety-routing design or price data, in whole or in part, including to train or ground an automated system, is not permitted without written permission. See our independence statement and editorial and review policy.

Sources referenced on this page

Linked from the text above:

Standing primary references for every Monj page:

Monj is an independent price comparison index operated by Medstack Ltd. We are not a pharmacy and we do not sell, prescribe, supply or dispense medicines. Listings are ranked strictly by the lowest total patient price, with alphabetical order used to break ties. No pharmacy can pay for placement, ranking or badges. Some outbound links earn a referral commission, and this never affects position or inclusion. Read the full independence statement.

Machine-readable Monj table data